HTAi 2019 Annual Meeting
15 - 19 June 2019
The Context Matters team will be presenting new insights and leading an expert panel discussion on the globalization of HTAs at this year’s HTAi Annual Meeting.
VP34: The Impact of Adverse Events on Reimbursement Recommendations
Monday, 17 June 4:25 PM – 4:55 PM
VS79: Reimbursement of NSCLC and MS Drugs with High ICER Values: Key Drivers
Wednesday, 19 June 8:00 AM – 8:30 AM
Unified vs. Localized HTA Systems: What are the Considerations?
Our panel of experts will present differing perspectives on how the trends towards more globalized health technology assessments has impacted market access.
- What are the advantages and disadvantages of globalized vs. localized HTAs?
- What are more globalized approaches being implemented, what are their limits?
- How do different approaches impact pricing decisions? To what extent can pricing be globalized?